The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease

Similar documents
Indications for catheter ablation in 2010: Ventricular Tachycardia

Prophylactic ablation

Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks

Focus on the role of Catheter Ablation: Simple cases Intermediate level Difficult cases (and patients) Impossible (almost )

Catheter Ablation of Recurrent Ventricular Tachycardia Should Be Done Before Antiarrhythmic Therapy with Amiodarone is Tried CONTRA

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm

ΔΠΔΜΒΑΣΙΚΗ ΘΔΡΑΠΔΙΑ ΚΟΙΛΙΑΚΩΝ ΑΡΡΤΘΜΙΩΝ

The patient with electric storm

ICD THERAPIES: are they harmful or just high risk markers?

Jean François Leclercq Department of Rythmology Private Hospital of Parly 2 - Le Chesnay F

Tachycardia Devices Indications and Basic Trouble Shooting

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center

Silvia G Priori MD PhD

The patient with (without) an ICD and heart failure: Management of electrical storm

Do All Patients With An ICD Indication Need A BiV Pacing Device?

Εκθορηίζεις απινιδωηή και θνηηόηηηα: μέθοδοι μείωζης ηων θεραπειών απινίδωζης

Two Years Living with the EHRA/HRS Consensus Document of VT Ablation: Need for an Update?

Ventricular arrhythmias in acute coronary syndromes. Dimitrios Manolatos, MD, PhD, FESC Electrophysiology Lab Evaggelismos General Hospital

Arrhythmias Focused Review. Who Needs An ICD?

ICD. Guidelines and Critical Review of Trials. Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011

that number is extremely high. It s 16 episodes, or in other words, it s 14, one-four, ICD shocks per patient per day.

Sudden death as co-morbidity in patients following vascular intervention

Treatment of VT of Purkinje fiber origin: ablation targets and outcome

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

Electrical Storm in Coronary Artery Disease. Saeed Oraii MD, Cardiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic July 2016

Primary prevention of SCD with the ICD in Nonischemic Cardiomyopathy

Shock Reduction Strategies Michael Geist E. Wolfson MC

Ventricular Arrhythmias

Secondary prevention of sudden cardiac death

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010

Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias

ICD Therapy. Disclaimers

Who does not need a primary preventive ICD?

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC

Novel Approaches to VT Management Glenn M Polin MD

ICD Shocks: How to Avoid? Josef Kautzner Department of Cardiology, Institute for Clinical and Experimental Medicine Prague, Czech Republic

Preventing Sudden Death Current & Future Role of ICD Therapy

The Role of ICD Therapy in Cardiac Resynchronization

New scientific documents from EHRA Management of patients with defibrillator shocks

Catheter ablation of monomorphic ventricular tachycardia. Department of Cardiology, IKEM, Prague, Czech Republic

Syncope in Heart Failure Patients How to judge and treat? Jean-Claude Deharo, MD, FESC Marseilles, France

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

3/23/2018. Complications of VAD Therapy: Arrhythmias. Disclosures. Agenda. I have no relevant disclosures

The ARREST Trial: Amiodarone for Resuscitation After Out-of-Hospital Cardiac Arrest Due to Ventricular Fibrillation

2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline. Top Ten Messages. Eleftherios M Kallergis, MD, PhD, FESC

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες

Device Update Implantable Cardioverter Defibrillator (ICD) 박상원

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation

- Special VT Cases - Idiopathic Dilated Cardiomyopathy. D. Bänsch

Erik Wissner, MD, F.A.C.C. Asklepios Klinik St. Georg Hamburg, Germany on behalf of the VTACH Study group

Devices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine

Mahmoud Suleiman MD. On behalf of the Israeli ICD Registry Scientific Committee. Jan 11, National ICD Registry

THE ROLE OF ICD THERAPY FOR PRIMARY PREVENTION Leonard Ganz, M.D. Pittsburgh, PA

Ventricular tachycardia ablation

Endpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD

Risk Stratification of Sudden Cardiac Death

Πρώτης γραμμή θεραπεία η κατάλυση κοιλιακής ταχυκαρδίας στην ισχαιμική μυοκαρδιοπάθεια

Need to Know: Implantable Devices. Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia

Recurrent refractory ventricular tachycardia in a patient with LVAD

Management of Syncope in Heart Failure. University of Iowa

Heart Rhythm Disorders. How do you quantify risk?

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.

Amiodarone Prescribing and Monitoring: Back to the Future

Treatment of Atrial Fibrillation in Heart Failure

Long-Term Outcome and Risks of Catheter Ablation for Atrial Fibrillation

Defibrillation threshold testing should no longer be performed: contra

EHRA EUROPACE How to perform epicardial ventricular tachycardia mapping and ablation

AF Today: W. For the majority of patients with atrial. are the Options? Chris Case

Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation

Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation?

Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice

SUDDEN CARDIAC DEATH(SCD): Definition

Inappropriate electrical shocks: Tackling the beast

SUDDEN CARDIAC DEATH(SCD): Definition

InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions

Arrhythmias Focused Review. Sustained Ventricular Tachycardia in Ischemic Cardiomyopathy: Current Management

ESC Stockholm Arrhythmias & pacing

Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure

Non-Invasive Ablation of Ventricular Tachycardia

Disclosures 8/29/2016. VT Ablation 2016: Indications and Expected Outcomes. Medtronic: advisory board, review panel. St Jude Medical: speakers bureau

Tachycardias II. Štěpán Havránek

When to implant an ICD in systemic right ventricle?

Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)

Ventricular tachycardia Ventricular fibrillation and ICD

Supplementary Online Content

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation

Case Report Successful Catheter Ablation of Persistent Electrical Storm late Post Myocardial Infarction by Targeting Purkinje Arborization Triggers

ROLE OF THE SIGNAL ECG IN RISK STRATIFICATION OF SCD. An overview

APPROACH TO TACHYARRYTHMIAS

עדכונים באלקטרופיזיולוגיה Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev

Summary, conclusions and future perspectives

Dipen Shah Cardiology Service, University Hospitals, Geneva Switzerland

Rebuttal. Jerónimo Farré MD 2010

Atrial fibrillation (AF) is a disorder seen

Map-Guided Ablation of Non-ischemic VT. Takashi Nitta Cardiovascular Surgery, Nippon Medical School Tokyo, JAPAN

Transcription:

The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease Paolo Della Bella, MD Arrhythmia Department and Clinical Electrophysiology Laboratories Ospedale San Raffaele, IRCCS, Milan, Italy

Arrhythmia treatment with ICD Problems The effect on overall survival is overestimated because of: The number of ICD shocks on fast VT is an independent predictor of mortality Arrhythmic storms affect adversely the long term prognosis In patients presenting with tolerated VT the incidence of SCD in ICD recipients equals that of patients treated only with catheter ablation

Arrhythmia treatment with ICD Problems The effect on overall survival is overestimated because of: The number of ICD shocks on fast VT is an independent predictor of mortality Arrhythmic storms affect adversely the long term prognosis In patients presenting with tolerated VT the incidence of SCD in ICD recipients equals that of patients treated only with catheter ablation

ICD firing itself is associated to increased mortality JACC, 1999 Circulation 2004

N Engl J Med. 2008

N Engl J Med. 2008

Arrhythmia treatment with ICD Problems The effect on overall survival is overestimated because of: The number of ICD shocks on fast VT is an independent predictor of mortality Arrhythmic storms affect adversely the long term prognosis In patients presenting with tolerated VT the incidence of SCD in ICD recipients equals that of patients treated only with catheter ablation

Electrical Storm Electrical Storm represents a relatively frequent complication (10-20%) in ICD recipients; it is commonly defined as the occurrence of 3 or more distinct VT episodes in a 24 hour period, each resulting in a DC shock. Refractory VTs are the most frequent arrythmia causing ES ES is an acute clinical emergency, and has been recognized as a significant independent predictor of cardiac death over the medium term in survivors (30 to 40% at two years), mainly due to arrhythmia recurrences External rescue DC shock

Electrical Storm a relatively frequent complication affecting ICD patients treated for secondary prevention of sudden cardiac death (about 20%) ES is a strong independent predictor of death in ICD patients (mortality between 38%-53%). Gatzoulis KA et al. Europace 2005; 7:184-92. Exner DV. et al. Circulation 2001; 103: 2066-71. Verma A et al. J C E 2004;15: 1265-70. cardiac death

317 ICD pts; causes of sudden cardiac death (90 pts, 28%) Mitchell LB, et al.; JACC 2002

Arrhythmia treatment with ICD Problems The effect on overall survival is overestimated because of: The number of ICD shocks on fast VT is an independent predictor of mortality Arrhythmic storms affect adversely the long term prognosis In patients presenting with tolerated VT the incidence of SCD in ICD recipients equals that of patients treated only with catheter ablation

Almendral J and Josephson M: Circulation 2007 In patients presenting with tolerated VT the incidence of SCD in ICD recipients equals that of patients treated only with catheter ablation Mean FU: 29 months

Cardiac Arrest or Death from Arrhythmia in the MUSTT trial -SCD in patients without ICD is 2.5% after acute success of CA at a mean 26 months follow up; -The rate of cardiac arrest or death from arrhythmia in patients with ICD in the MUST Study was 6% at 3 yrs and 9% at 5 yrs Buxton et al: N Engl J Med 1999

Solutions CATHETER ABLATION IS AN EFFECTIVE TREATMENT TO REDUCE ICD SHOCKS SUCCESSFUL CATHETER ABLATION PREVENTS ARRHYTHMIA STORM RECURRENCE AND RELATED MORTALITY

CATHETER ABLATION IS AN EFFECTIVE TREATMENT TO REDUCE ICD SHOCKS Reddy VY et al.; NEJM 2007

Carbucicchio C, Circulation 2008 Multiple morphologies and untolerated VT induction frequently occurr in patients with ES Catheter ablation is successsful in up to 72% of patients with ES

Carbucicchio C, Circulation 2008

Acute outcome of catheter ablation in 163 patients presenting with Arrhythmic storm/incessant VT (415 pts referred for VT between 2007-2010) 12; 7% 4; 2% 3; 2% 5; 3% 37; 23% 102; 63% 124 pts presenting with ES 39 pts presenting with incessant VT Initial DCM CAD IDCM ARVD VALVULAR HCM

Cumulative Arrhythmic and Heart Failure Death Among pts presenting with ES P=0.008

Treatment and acute outcome of VT catheter ablation (353 of 415 pts referred for VT between 2007-2010) N pts 300 284-79% 250 200 256-71% Endo RFCA Epi RFCA Surgical ablation 150 RFCA success (A class) 100 80-23% RFCA partial success (B Class) 50 46-12% Failure (C Class ) 0 23-6% 13-4% 16-5% Successful ablation of target VT - Control PES not performed

Long term results related to acute outcome N pts 300 3% 21% 250 200 150 ES recurrence Paroxysmal VT Recurrence No recurrence 100 76% 50 0 5% 30% 100% 9% 65% 81% Class A: 284 pts Class B: 46 pts Class C 13 pts non tested 16 pts In hospital recurrence of VT storm requiring REDO procedure in 14 pts (4%) In hospital recurrence of paroxysmal VT in 56 pts (15%)

Procedure-related complications Tab. 1 Vascular injury (not requiring surgery) 3% AV fistula/pseudoaneurysm (surgical repair) 2% Pericardial effusion Total 2% Cardiac tamponade 1% Cardiac tamponade (surgical repair) 0.4% Pulmonary edema 1% PEA 0.5% Subacute haemoperitoneum (injury to diafragmatic vessel during epicardal puncture) 0.2%

Mortality In Hospital death 7 Heart Failure Intraprocedure PEA 6 1 Long term follow up 28 ±6 months All cause death HF death Cardiac arrest 37 12 21

VT/VF Arrhythmia storm Need for an integrated approach Anaesthesiology support in the acute phase aimed to: Cardiorespiratory function support Sedation / reduction of sympathetic drive Hemodynamic support (IABP, ECMO) Recovery in the Intensive Care Unit in selected instances Mechanical support (VAD) Cardiac surgery to provide map guided arrhythmia surgery in selected cases.

The ICD is not enough Key issues ICD reprogramming CONCLUSIONS: Shocked VA episodes are associated with increased mortality risk. Shocked patients have substantially higher VA episode burden and poorer survival compared with ATP-only treated patients. Sweeney MO, et al. Heart Rhythm. Mar 2010

The ICD is not enough Key issues Optimize drug treatment Amiodarone and betablockers therapy lead to a reduction of appropriate ICD shocks comparable to SMASH trial (annual event rate: 6.7%), Hazard ratio: 0.3 (CI: 0.14-0.68) in patients receiving an ICD for primary SD prevention Connolly SJ, et al. The Optic study JAMA Jan 2006 But a rate of 18% /year of amiodarone discontinuation caused by side effect was observed in the same study!

Connolly SJ, et al. The Optic study JAMA Jan 2006

The ICD is not enough Key issues Open points: timing of catheter ablation is not well defined Should Substrate Ablation be performed in patients with old myocardial infarction after unstable VT/VF occurrence before planning an ICD implantation? Should VT Ablation be performed in all patients presenting with post-mi stable monomorphic VT before ICD implantation to reduce ICD therapies burden?

128 pts with previuos Myocardial infarction and severe LV dysfunction Enrollement criteria: 1) Indication to ICD implantation related to: -Spontaneous VF or unstable VT -Syncope and VT induction at EPS - Mean LVEF: 0.25 2) ICD implantation for primary prophylaxis and appropriate ICD therapy for a single event Randomized to: no treatment or substrate catheter ablation during sinus rhythm No AAds (except for betablockers) in control group!

No evidence of survival benefit Overall reduction of ICD therapies burden in the ablation group with respect to control group

No significant improvement of arrhythmia-free survival is demonstrated in the group of patients with severe LV dysfunction Kuck KH et al. Lancet. 2010

Conclusions Carefully define indications to ICD implantation Curative treatment should be considered earlier in the arrhythmia hystory and definitely after the first episode of appropriate shock Concomitant medical treatment is an option (no evidence at this time whether drug treatment should precede ablation) ICD programming to ATP: consider however that the powerful prognostic indicator is not only the mode of arrhythmia termination, but rather the associated arrhythmia burden